Initially inserted percutaneously for malignant biliary stenoses, expandabl
e gastrointestinal prostheses have evolved as primary treatment for maligna
nt dysphagia and as an alternative to plastic prostheses for some types of
obstructive jaundice. They are also in their infancy as a means to palliate
unresectable obstructions of the gastric outlet, small bower, and colorect
um. Despite a decade of development, problems persist and include: maldeplo
yment; inadequate expansion; ingrowth; overgrowth; erosion, and migration.
This article outlines some of the problems noted and opportunities to impro
ve this still-evolving technology.